当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析 - 现金流量表

国药股份

(600511)

  

流通市值:149.68亿  总市值:204.09亿
流通股本:5.53亿   总股本:7.55亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金27,306,154,42111,974,375,550.6656,483,077,866.2739,821,987,410.31
  收到的税费返还172,277.364,378.49666,271.29588,977.41
  收到其他与经营活动有关的现金218,676,012.37153,374,814.3841,752,743.23368,254,545.51
  经营活动现金流入小计27,525,002,710.7312,127,754,743.4557,325,496,880.7940,190,830,933.23
  购买商品、接受劳务支付的现金28,025,948,968.614,500,335,656.4951,550,999,642.439,468,754,090.53
  支付给职工以及为职工支付的现金433,124,345.43236,106,843.75854,542,592.38626,161,020.19
  支付的各项税费836,414,856.6419,149,061.641,771,229,006.981,128,095,920.77
  支付其他与经营活动有关的现金863,858,088.85565,113,976.971,143,208,126.971,018,252,683.85
  经营活动现金流出小计30,159,346,259.4815,720,705,538.8555,319,979,368.7342,241,263,715.34
  经营活动产生的现金流量净额-2,634,343,548.75-3,592,950,795.42,005,517,512.06-2,050,432,782.11
二、投资活动产生的现金流量:
  收回投资收到的现金3,094,248.873,094,248.8718,329,499.933,139,870.64
  取得投资收益收到的现金45,986,567.23-32,273,886.7829,327,149.2
  处置固定资产、无形资产和其他长期资产收回的现金净额18,292.25,107.2202,302.2578,328.63
  收到的其他与投资活动有关的现金500,000,000---
  投资活动现金流入小计549,099,108.33,099,356.0750,805,688.9632,545,348.47
  购建固定资产、无形资产和其他长期资产支付的现金29,269,085.956,420,132.868,194,378.1740,419,863.94
  投资活动现金流出小计29,269,085.956,420,132.868,194,378.1740,419,863.94
  投资活动产生的现金流量净额519,830,022.35-3,320,776.73-17,388,689.21-7,874,515.47
三、筹资活动产生的现金流量:
  取得借款收到的现金216,000,000106,000,000319,447,721.2319,447,721.2
  筹资活动现金流入小计216,000,000106,000,000319,447,721.2319,447,721.2
  偿还债务支付的现金174,449,759.21148,363,906.68923,448,321.92636,348,932.49
  分配股利、利润或偿付利息支付的现金610,652,630.074,892,203.06653,281,757.75644,787,849.53
  其中:子公司支付给少数股东的股利、利润--27,543,689.5124,433,001.58
  支付其他与筹资活动有关的现金67,570,243.9239,408,192.35130,194,249.04114,391,693.18
  筹资活动现金流出小计852,672,633.2192,664,302.091,706,924,328.711,395,528,475.2
  筹资活动产生的现金流量净额-636,672,633.2-86,664,302.09-1,387,476,607.51-1,076,080,754
五、现金及现金等价物净增加额-2,751,186,159.6-3,682,935,874.22600,652,215.34-3,134,388,051.58
  加:期初现金及现金等价物余额8,892,046,272.38,892,046,272.38,291,394,056.968,291,394,056.96
  期末现金及现金等价物余额6,140,860,112.75,209,110,398.088,892,046,272.35,157,006,005.38
补充资料:
  净利润874,248,629.54-2,089,403,586-
  资产减值准备47,378,719.81-5,563,843.29-
  固定资产和投资性房地产折旧33,978,673.1-73,297,846.2-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧33,978,673.1-73,297,846.2-
  无形资产摊销26,818,931.77-54,366,923.24-
  长期待摊费用摊销4,289,706.64-10,067,575.5-
  处置固定资产、无形资产和其他长期资产的损失20,108.4--212,185.96-
  固定资产报废损失--102,985.11-
  公允价值变动损失---66,164.34-
  财务费用10,785,139.64-27,165,852.32-
  投资损失-286,926,112.79--585,314,905.57-
  递延所得税-18,096,209.99--20,566,368.53-
  其中:递延所得税资产减少-15,906,233.7--14,177,873.67-
    递延所得税负债增加-2,189,976.29--6,388,494.86-
  存货的减少-274,551,573.66--240,873,051.48-
  经营性应收项目的减少-2,465,680,181.47--692,570,321.85-
  经营性应付项目的增加-705,639,822.14-1,140,496,132.06-
  其他574,495.08---
  现金的期末余额6,140,860,112.7-8,892,046,272.3-
  减:现金的期初余额8,892,046,272.3-8,291,394,056.96-
  现金及现金等价物的净增加额-2,751,186,159.6-600,652,215.34-
公告日期2026-08-202026-04-232026-03-202025-10-22
审计意见(境内)标准无保留意见
TOP↑